Other languages Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Market Closed - Bombay S.E. Other stock markets 11:01:01 05/06/2024 BST			5-day change	1st Jan Change
107.6 ^INR	+2.58%		+7.39%	+7.01%

05-28	Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-12	Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bal Pharma Limited Recommends Dividend	05-28
Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-28
Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12
Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08
Bal Pharma Limited Approves Dividend	25/09/23
Bal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Bal Pharma Limited Appoints Abdul Basith as Company Secretary and Compliance Officer	17/07/23
Bal Pharma Limited Appoints Nicola Neeladri as Additional Director	01/06/23
Bal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/05/23
Bal Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/05/23
Bal Pharma Limited Recommends Dividend	29/05/23
Bal Pharma Limited Announces Resignation of Mrs.Preeti Singh as Company Secretary	15/05/23
Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	06/02/23
Bal Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14/11/22
Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22
Bal Pharma Limited Declares Dividend	19/09/22
Bal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/08/22
Bal Pharma Limited Appoints Kotian Chittananda Damodar as Additional Director (Non Independent)	30/05/22
Bal Pharma Limited Recommends Dividend	30/05/22
Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	10/02/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Other languages

Filters